| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bdd76bb47a77dfb71e36e84d08c9a9dd |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-50 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2020-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2022-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a41c8472395e0e23d39500ea4f72afe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d272c97d7df504ba3f02a2af5bf943ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_129f25ae1d2553ec2d71254a64e24b45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0c680fbc88ab237cc4510e2448735f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e1deedfed9c1986d9113031cdb420c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fda47ad4b541ce83ee8492b416447f74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37822948c4ca5ec040361cf6ccab5428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e8052d2493449008eb4fe55942f841f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_006462898707b2688f72517e06ac78e0 |
| publicationDate |
2022-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2765545-C1 |
| titleOfInvention |
2-amino-1-benzamido-5-(3,3-dimethyl-2-oxobutylidene)-4-oxo-4,5-dihydro-1h-pyrrol-3-carboxamide causing irregularities in the phases of the cell cycle and exhibiting cytotoxic activity against soft tissue sarcomas and gastrointestinal stromal tumours (gist) |
| abstract |
FIELD: pharmaceuticals. n SUBSTANCE: invention relates to an application of 2-amino-1-benzamido-5-(3,3-dimethyl-2-oxobutylidene)-4-oxo-4,5-dihydro-1H-pyrrol-3-carboxamide I by the formula below for producing an anti-tumour medicinal product. n EFFECT: compound exhibits cytotoxic activity against soft tissue sarcomas and gastrointestinal stromal tumours. n n n n 1 cl, 3 dwg, 2 tbl |
| priorityDate |
2020-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |